Drug industry only to survive by core and competence strategy.

Given the situation where most of local pharmaceutical industries have encountered with many external environmental challenges such as the FTA with the United States, the adoption of new drug pricing control system called "Positive list system" and the new GMP system, they should overcome the crisis by adopting a core and competence strategy in the product portfolio and therapeutic business are...